Company profile
Iox Therapeutics Limited is a UK company with status active founded in 2015 based in London.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
The company is centred around development of the use of NKT cell agonists in cancer patients. The close affiliation with the Ludwig Institute will provide access to GMP grade recombinant tumour antigens, which will be used in combination with proprietary GMP grade NKT cell agonists in the clinic. We have recently secured funding from the EC (Horizon 2020), with iOx being listed as a co-applicant.
None yet
